🟢 Envista Holdings is trading 7.14% up in pre-market amid healthcare-sector gains

Envista Holdings is trading at $24.45, up 7.14% pre-market; healthcare-sector strength offers context, but no direct catalyst is confirmed.

• Healthcare is up 1.45% pre-market amid defensive rotation.
• Leerink’s October 14 price-target cut came with an Outperform rating, but does not explain the rise.
• Envista’s Q3 report is scheduled for November 4, 2026.